Results-focused and highly accomplished financial and operating leader with progressive record of exceptional performance championing global expansion, restructuring, and mergers and acquisitions (M&A) efforts for global Fortune 500 companies. .. SEE MORE
Success includes accelerating revenue growth, improving margins, and inspiring stakeholders and high-performing teams to realize new levels of performance and profit for operations in North America, EMEA, LATAM and APAC. Shapes corporate strategy and introduces financial and operating controls. Plays crucial role in business-building, leveraging data and analysis, and strategic planning to bring competitive advantage. Leverages technical expertise in SOX, US GAAP, IFRS, and external and internal audit processes to protect company interests. Builds meaningful relationships, sets unified direction for team, and instills high standards of excellence organization wide. Bilingual: English / French.
BOSTON SCIENTIFIC NEUROMODULATION | Valencia, CA 2015 - Feb 2023
Global leader in microelectronic implantable technologies for chronic pain and neurological diseases.
Vice President Finance - Sales Operations and Analytics
Serve in high-profile leadership role with accountability for FP&A, accounting, sales operations and reporting, and analytics. Identify trends, inform forecast models, and advise executive leadership and divisional teams to fuel top- and bottom-line performance, including maintaining ownership of global KPIs. Ensure delivery of GAAP-compliant month-end close. Oversee sales organization with integrated revenue support, technology, and process improvement to enable scale for growth. Manage performance of 25+ staff and report to divisional president.
BOSTON SCIENTIFIC | Paris, France 2006 - 2015
Director of Finance - Cardiology & Structural Heart EMEA (2011 - 2015)
Led FP&A for cardiology business in EMEA and served as financial controller for efforts in France and UK. Articulated business performance through data-driven insights and effective storytelling. Managed and reported on combined $700M budget for France and UK and cardiology in Europe. Reported to VP cardiology in EMEA.
Controller - France (2006 - 2011)
Added value as finance leader in charge of FP&A and accounting with team of eight direct reports and $300M budget. Enhanced T&E compliance through proactive coaching and controls enforcement. Reported to country president.
IMPERIAL CHEMICAL INDUSTRIES (ICI) | Paris, France 2003 - 2006
British chemical company acquired by AkzoNobel in 2008.
Director - FP&A
Oversaw efforts of six staff managing single plant. Improved data analytics to support sales team in contracting with major distributors. Led implementation of SOX. Improved standard cost by 5%+ YoY and advanced plant's profitability. Developed planning tool in Excel.
ARTHUR ANDERSEN | Paris, France 1998 - 2003
American accounting firm that provided auditing, tax advising, consulting, and professional services to large corporations.
Senior Manager - Audit
Performed due diligence for private equity firms and major companies, including leading internet company acquisition in France. Led field work, completing audit processes, and documenting higher-risk areas for industrial and services companies. Participated in client pursuit efforts.
3M | le-de-France, France 1995 - 1998
American multinational conglomerate operating in fields of industry, worker safety, US healthcare, and consumer goods (NYSE: MMM).
Manufacturing FP&A
Managed Post-It Notes products line. Drove effort to reduce costs by 25% through improved packaging. Oversaw budgeting, forecasting, reporting, and OPEX analysis.
